APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bivalent HPV Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Bivalent HPV Vaccines Industry Growth and Trends Forecast to 2032

20 December 202597 pages

Choose your research edition.

Industry ResearchBivalent HPV Vaccines Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Bivalent HPV Vaccines Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Bivalent HPV Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bivalent HPV Vaccines Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Bivalent HPV Vaccines Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Bivalent HPV Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bivalent HPV Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bivalent HPV Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bivalent HPV Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bivalent HPV Vaccines include Yunnan Watson Biotechnology Co.,Ltd., Jiangsu Ruike Biotechnology Co.,Ltd., GSK, Beijing Wantai Biopharmaceutical Co.,Ltd. and MSD, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bivalent HPV Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bivalent HPV Vaccines market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bivalent HPV Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bivalent HPV Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bivalent HPV Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bivalent HPV Vaccines Market by Company

Yunnan Watson Biotechnology Co.,Ltd.

Jiangsu Ruike Biotechnology Co.,Ltd.

GSK

Beijing Wantai Biopharmaceutical Co.,Ltd.

MSD

Bivalent HPV Vaccines Segment by Type

Adolescents

Adults

Bivalent HPV Vaccines Segment by Application

General Hospital

Community Hospital

CDC

Maternal and Child Health Hospital

Bivalent HPV Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bivalent HPV Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bivalent HPV Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bivalent HPV Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bivalent HPV Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bivalent HPV Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Adolescents Table 2. Major Company of Adults Table 3. Global Bivalent HPV Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Bivalent HPV Vaccines Sales by Type (2021-2026) & (k units) Table 5. Global Bivalent HPV Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Bivalent HPV Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Bivalent HPV Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Bivalent HPV Vaccines Price by Type (2021-2026) & (US$/unit) Table 9. Global Bivalent HPV Vaccines Sales by Type (2027-2032) & (k units) Table 10. Global Bivalent HPV Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Bivalent HPV Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Bivalent HPV Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Bivalent HPV Vaccines Price by Type (2027-2032) & (US$/unit) Table 14. North America Bivalent HPV Vaccines Sales by Type (2021-2026) & (k units) Table 15. North America Bivalent HPV Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Bivalent HPV Vaccines Sales by Type (2021-2026) & (k units) Table 17. Europe Bivalent HPV Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Bivalent HPV Vaccines Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Bivalent HPV Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Bivalent HPV Vaccines Sales by Type (2021-2026) & (k units) Table 21. Latin America Bivalent HPV Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Bivalent HPV Vaccines Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Bivalent HPV Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Bivalent HPV Vaccines Industry Trends Table 25. Bivalent HPV Vaccines Industry Drivers Table 26. Bivalent HPV Vaccines Industry Opportunities and Challenges Table 27. Bivalent HPV Vaccines Industry Restraints Table 28. Global Bivalent HPV Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Bivalent HPV Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Bivalent HPV Vaccines Sales by Company (2021-2026) & (k units) Table 31. Global Bivalent HPV Vaccines Sales Share by Company (2021-2026) Table 32. Global Bivalent HPV Vaccines Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Bivalent HPV Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Bivalent HPV Vaccines Major Company Production Sites and Headquarters Table 35. Global Bivalent HPV Vaccines Company, Product Type & Application Table 36. Global Bivalent HPV Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Bivalent HPV Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Bivalent HPV Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Bivalent HPV Vaccines Sales by Region (2021-2026) & (k units) Table 41. Global Bivalent HPV Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Bivalent HPV Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Bivalent HPV Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Bivalent HPV Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Bivalent HPV Vaccines Sales by Region (2027-2032) & (k units) Table 46. Global Bivalent HPV Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Bivalent HPV Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Bivalent HPV Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Bivalent HPV Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Bivalent HPV Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Bivalent HPV Vaccines Sales by Application (2021-2026) & (k units) Table 52. Global Bivalent HPV Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Bivalent HPV Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Bivalent HPV Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Bivalent HPV Vaccines Price by Application (2021-2026) & (US$/unit) Table 56. Global Bivalent HPV Vaccines Sales by Application (2027-2032) & (k units) Table 57. Global Bivalent HPV Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Bivalent HPV Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Bivalent HPV Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Bivalent HPV Vaccines Price by Application (2027-2032) & (US$/unit) Table 61. North America Bivalent HPV Vaccines Sales by Application (2021-2026) & (k units) Table 62. North America Bivalent HPV Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Bivalent HPV Vaccines Sales by Application (2021-2026) & (k units) Table 64. Europe Bivalent HPV Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Bivalent HPV Vaccines Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Bivalent HPV Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Bivalent HPV Vaccines Sales by Application (2021-2026) & (k units) Table 68. Latin America Bivalent HPV Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Bivalent HPV Vaccines Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Bivalent HPV Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Yunnan Watson Biotechnology Co.,Ltd. Company Information Table 72. Yunnan Watson Biotechnology Co.,Ltd. Business Overview Table 73. Yunnan Watson Biotechnology Co.,Ltd. Bivalent HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Yunnan Watson Biotechnology Co.,Ltd. Bivalent HPV Vaccines Product Portfolio Table 75. Yunnan Watson Biotechnology Co.,Ltd. Recent Development Table 76. Jiangsu Ruike Biotechnology Co.,Ltd. Company Information Table 77. Jiangsu Ruike Biotechnology Co.,Ltd. Business Overview Table 78. Jiangsu Ruike Biotechnology Co.,Ltd. Bivalent HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Jiangsu Ruike Biotechnology Co.,Ltd. Bivalent HPV Vaccines Product Portfolio Table 80. Jiangsu Ruike Biotechnology Co.,Ltd. Recent Development Table 81. GSK Company Information Table 82. GSK Business Overview Table 83. GSK Bivalent HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. GSK Bivalent HPV Vaccines Product Portfolio Table 85. GSK Recent Development Table 86. Beijing Wantai Biopharmaceutical Co.,Ltd. Company Information Table 87. Beijing Wantai Biopharmaceutical Co.,Ltd. Business Overview Table 88. Beijing Wantai Biopharmaceutical Co.,Ltd. Bivalent HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Beijing Wantai Biopharmaceutical Co.,Ltd. Bivalent HPV Vaccines Product Portfolio Table 90. Beijing Wantai Biopharmaceutical Co.,Ltd. Recent Development Table 91. MSD Company Information Table 92. MSD Business Overview Table 93. MSD Bivalent HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. MSD Bivalent HPV Vaccines Product Portfolio Table 95. MSD Recent Development Table 96. North America Bivalent HPV Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 97. North America Bivalent HPV Vaccines Sales by Country (2021-2026) & (k units) Table 98. North America Bivalent HPV Vaccines Sales Market Share by Country (2021-2026) Table 99. North America Bivalent HPV Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 100. North America Bivalent HPV Vaccines Sales Market Share Forecast by Country (2027-2032) Table 101. North America Bivalent HPV Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Bivalent HPV Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Bivalent HPV Vaccines Market Share by Country (2021-2026) Table 104. North America Bivalent HPV Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Bivalent HPV Vaccines Market Share Forecast by Country (2027-2032) Table 106. Europe Bivalent HPV Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. Europe Bivalent HPV Vaccines Sales by Country (2021-2026) & (k units) Table 108. Europe Bivalent HPV Vaccines Sales Market Share by Country (2021-2026) Table 109. Europe Bivalent HPV Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 110. Europe Bivalent HPV Vaccines Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Bivalent HPV Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Bivalent HPV Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Bivalent HPV Vaccines Market Share by Country (2021-2026) Table 114. Europe Bivalent HPV Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Bivalent HPV Vaccines Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Bivalent HPV Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Bivalent HPV Vaccines Sales by Country (2021-2026) & (k units) Table 118. Asia-Pacific Bivalent HPV Vaccines Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Bivalent HPV Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 120. Asia-Pacific Bivalent HPV Vaccines Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Bivalent HPV Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Bivalent HPV Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Bivalent HPV Vaccines Market Share by Country (2021-2026) Table 124. Asia-Pacific Bivalent HPV Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Bivalent HPV Vaccines Market Share Forecast by Country (2027-2032) Table 126. Latin America Bivalent HPV Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Latin America Bivalent HPV Vaccines Sales by Country (2021-2026) & (k units) Table 128. Latin America Bivalent HPV Vaccines Sales Market Share by Country (2021-2026) Table 129. Latin America Bivalent HPV Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 130. Latin America Bivalent HPV Vaccines Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Bivalent HPV Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Bivalent HPV Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Bivalent HPV Vaccines Market Share by Country (2021-2026) Table 134. Latin America Bivalent HPV Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Bivalent HPV Vaccines Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Bivalent HPV Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Bivalent HPV Vaccines Sales by Country (2021-2026) & (k units) Table 138. Middle East and Africa Bivalent HPV Vaccines Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Bivalent HPV Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 140. Middle East and Africa Bivalent HPV Vaccines Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Bivalent HPV Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Bivalent HPV Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Bivalent HPV Vaccines Market Share by Country (2021-2026) Table 144. Middle East and Africa Bivalent HPV Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Bivalent HPV Vaccines Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Bivalent HPV Vaccines Distributors List Table 149. Bivalent HPV Vaccines Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Bivalent HPV Vaccines Image Figure 2. Global Bivalent HPV Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bivalent HPV Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Bivalent HPV Vaccines Sales (2021-2032) & (k units) Figure 5. Adolescents Image Figure 6. Global Adolescents Sales YoY Growth (2021-2032) & (k units) Figure 7. Adults Image Figure 8. Global Adults Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Bivalent HPV Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Bivalent HPV Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Bivalent HPV Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Bivalent HPV Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Bivalent HPV Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Bivalent HPV Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Bivalent HPV Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Bivalent HPV Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Bivalent HPV Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Bivalent HPV Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Bivalent HPV Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Bivalent HPV Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Bivalent HPV Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. General Hospital Image Figure 24. Global General Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Community Hospital Image Figure 26. Global Community Hospital Sales YoY Growth (2021-2032) & (k units) Figure 27. CDC Image Figure 28. Global CDC Sales YoY Growth (2021-2032) & (k units) Figure 29. Maternal and Child Health Hospital Image Figure 30. Global Maternal and Child Health Hospital Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Bivalent HPV Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Bivalent HPV Vaccines Market Share by Application 2025 VS 2032 Figure 33. North America Bivalent HPV Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. North America Bivalent HPV Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Europe Bivalent HPV Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Europe Bivalent HPV Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Bivalent HPV Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Bivalent HPV Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Latin America Bivalent HPV Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Bivalent HPV Vaccines Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Bivalent HPV Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Bivalent HPV Vaccines Sales Market Share in Value by Application in 2025 Figure 43. North America Bivalent HPV Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Bivalent HPV Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Bivalent HPV Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Bivalent HPV Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Bivalent HPV Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Bivalent HPV Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Bivalent HPV Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Bivalent HPV Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Bivalent HPV Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Bivalent HPV Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Bivalent HPV Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Bivalent HPV Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Bivalent HPV Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Bivalent HPV Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Bivalent HPV Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Bivalent HPV Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Bivalent HPV Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Bivalent HPV Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Bivalent HPV Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Bivalent HPV Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Bivalent HPV Vaccines Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Bivalent HPV Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Adolescents
  • Adults
Applications
  • General Hospital
  • Community Hospital
  • CDC
  • Maternal and Child Health Hospital
Companies covered
  • Yunnan Watson Biotechnology Co.,Ltd.
  • Jiangsu Ruike Biotechnology Co.,Ltd.
  • GSK
  • Beijing Wantai Biopharmaceutical Co.,Ltd.
  • MSD

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bivalent HPV Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bivalent HPV Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bivalent HPV Vaccines Market by Type
  6. 1.3.1 Adolescents
  7. 1.3.2 Adults
  8. 1.4 Global Bivalent HPV Vaccines Market Size by Type
  9. 1.4.1 Global Bivalent HPV Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Bivalent HPV Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Bivalent HPV Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Bivalent HPV Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Bivalent HPV Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Bivalent HPV Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Bivalent HPV Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Bivalent HPV Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bivalent HPV Vaccines Industry Trends
  2. 2.2 Bivalent HPV Vaccines Industry Drivers
  3. 2.3 Bivalent HPV Vaccines Industry Opportunities and Challenges
  4. 2.4 Bivalent HPV Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bivalent HPV Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Bivalent HPV Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Bivalent HPV Vaccines Price (2021-2026)
  4. 3.4 Global Bivalent HPV Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bivalent HPV Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Bivalent HPV Vaccines Company, Product Type & Application
  7. 3.7 Global Bivalent HPV Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bivalent HPV Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bivalent HPV Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bivalent HPV Vaccines Tier 1, Tier 2, and Tier 3
4 Bivalent HPV Vaccines Regional Status and Outlook
  1. 4.1 Global Bivalent HPV Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bivalent HPV Vaccines Historic Market Size by Region
  3. 4.2.1 Global Bivalent HPV Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bivalent HPV Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bivalent HPV Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bivalent HPV Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Bivalent HPV Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bivalent HPV Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bivalent HPV Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bivalent HPV Vaccines by Application
  1. 5.1 Bivalent HPV Vaccines Market by Application
  2. 5.1.1 General Hospital
  3. 5.1.2 Community Hospital
  4. 5.1.3 CDC
  5. 5.1.4 Maternal and Child Health Hospital
  6. 5.2 Global Bivalent HPV Vaccines Market Size by Application
  7. 5.2.1 Global Bivalent HPV Vaccines Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Bivalent HPV Vaccines Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Bivalent HPV Vaccines Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Bivalent HPV Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Bivalent HPV Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Bivalent HPV Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Bivalent HPV Vaccines Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Bivalent HPV Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yunnan Watson Biotechnology Co.,Ltd.
  2. 6.1.1 Yunnan Watson Biotechnology Co.,Ltd. Company Information
  3. 6.1.2 Yunnan Watson Biotechnology Co.,Ltd. Business Overview
  4. 6.1.3 Yunnan Watson Biotechnology Co.,Ltd. Bivalent HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yunnan Watson Biotechnology Co.,Ltd. Bivalent HPV Vaccines Product Portfolio
  6. 6.1.5 Yunnan Watson Biotechnology Co.,Ltd. Recent Developments
  7. 6.2 Jiangsu Ruike Biotechnology Co.,Ltd.
  8. 6.2.1 Jiangsu Ruike Biotechnology Co.,Ltd. Company Information
  9. 6.2.2 Jiangsu Ruike Biotechnology Co.,Ltd. Business Overview
  10. 6.2.3 Jiangsu Ruike Biotechnology Co.,Ltd. Bivalent HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Jiangsu Ruike Biotechnology Co.,Ltd. Bivalent HPV Vaccines Product Portfolio
  12. 6.2.5 Jiangsu Ruike Biotechnology Co.,Ltd. Recent Developments
  13. 6.3 GSK
  14. 6.3.1 GSK Company Information
  15. 6.3.2 GSK Business Overview
  16. 6.3.3 GSK Bivalent HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GSK Bivalent HPV Vaccines Product Portfolio
  18. 6.3.5 GSK Recent Developments
  19. 6.4 Beijing Wantai Biopharmaceutical Co.,Ltd.
  20. 6.4.1 Beijing Wantai Biopharmaceutical Co.,Ltd. Company Information
  21. 6.4.2 Beijing Wantai Biopharmaceutical Co.,Ltd. Business Overview
  22. 6.4.3 Beijing Wantai Biopharmaceutical Co.,Ltd. Bivalent HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Beijing Wantai Biopharmaceutical Co.,Ltd. Bivalent HPV Vaccines Product Portfolio
  24. 6.4.5 Beijing Wantai Biopharmaceutical Co.,Ltd. Recent Developments
  25. 6.5 MSD
  26. 6.5.1 MSD Company Information
  27. 6.5.2 MSD Business Overview
  28. 6.5.3 MSD Bivalent HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 MSD Bivalent HPV Vaccines Product Portfolio
  30. 6.5.5 MSD Recent Developments
7 North America by Country
  1. 7.1 North America Bivalent HPV Vaccines Sales by Country
  2. 7.1.1 North America Bivalent HPV Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bivalent HPV Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Bivalent HPV Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bivalent HPV Vaccines Market Size by Country
  6. 7.2.1 North America Bivalent HPV Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bivalent HPV Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Bivalent HPV Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bivalent HPV Vaccines Sales by Country
  2. 8.1.1 Europe Bivalent HPV Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bivalent HPV Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Bivalent HPV Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bivalent HPV Vaccines Market Size by Country
  6. 8.2.1 Europe Bivalent HPV Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bivalent HPV Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bivalent HPV Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bivalent HPV Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Bivalent HPV Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bivalent HPV Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bivalent HPV Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bivalent HPV Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Bivalent HPV Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bivalent HPV Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bivalent HPV Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bivalent HPV Vaccines Sales by Country
  2. 10.1.1 South America Bivalent HPV Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bivalent HPV Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Bivalent HPV Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bivalent HPV Vaccines Market Size by Country
  6. 10.2.1 South America Bivalent HPV Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bivalent HPV Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Bivalent HPV Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bivalent HPV Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Bivalent HPV Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bivalent HPV Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bivalent HPV Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bivalent HPV Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Bivalent HPV Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bivalent HPV Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bivalent HPV Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bivalent HPV Vaccines Value Chain Analysis
  2. 12.1.1 Bivalent HPV Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bivalent HPV Vaccines Production Mode & Process
  7. 12.2 Bivalent HPV Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bivalent HPV Vaccines Distributors
  10. 12.2.3 Bivalent HPV Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst